Chinese authorities have ordered a fine and asset seizure totalling $1.3bn against a pharmaceutical company for falsifying production records in a faulty rabies vaccine scandal.
Changchun Changsheng Life Sciences Ltd, which was ordered in July to suspend production, was also stripped of its licences to make vaccines and drugs, the China National Drug Administration (CNDA) announced on Tuesday.
Violations included blending different batches of vaccine fluid, falsifying dates of production and using expired fluid to produce some of the batches, the document said.
In addition, the SDA imposed a fine and removed the company’s drug approval certificate for the vaccine, according to an announcement from the government.
The hefty fine of 7.21 billion yuan was three times the total value of the defective vaccines produced and sold by the company, reports Xinhuanet.com.
The firm’s chairwoman and 14 other people were arrested in connection with the misconduct in July after a surprise inspection found falsified production and inspection records starting as early as 2014.
Changsheng Changsheng is China’s second-largest rabies vaccine maker and is also the country’s second-largest chickenpox vaccine provider, according to its 2017 annual report.